DCM
DAFNA Capital Management Portfolio holdings
AUM
$362M
This Quarter Return
+56.7%
1 Year Return
-0.48%
3 Year Return
+117.01%
5 Year Return
+181.93%
10 Year Return
+1,483.26%
AUM
$347M
AUM Growth
+$347M
(+45%)
Cap. Flow
+$1.2M
Cap. Flow
% of AUM
0.35%
Top 10 Holdings %
Top 10 Hldgs %
48.52%
Holding
96
New
16
Increased
10
Reduced
35
Closed
8
Top Buys
| 1 |
IMMU
Immunomedics Inc
IMMU
|
$8.89M |
| 2 |
DRNA
Dicerna Pharmaceuticals, Inc.
DRNA
|
$7.79M |
| 3 |
Syndax Pharmaceuticals
SNDX
|
$5.34M |
| 4 |
CNST
Constellation Pharmaceuticals, Inc.
CNST
|
$5.14M |
| 5 |
Liquidia Corp
LQDA
|
$4.63M |
Top Sells
| 1 |
Corbus Pharmaceuticals
CRBP
|
$5.37M |
| 2 |
DexCom
DXCM
|
$4.95M |
| 3 |
AtriCure
ATRC
|
$4.79M |
| 4 |
Compugen
CGEN
|
$3.86M |
| 5 |
Mersana Therapeutics
MRSN
|
$3.08M |
Sector Composition
| 1 | Healthcare | 88.42% |
